Chemical inhibitors of epsin2 include a variety of compounds that target different aspects of the endocytic pathway in which epsin2 is a key player. Pitstop 2 directly inhibits clathrin, a protein that forms a polyhedral lattice around vesicles as they bud from the plasma membrane, which is a process facilitated by epsin2. By binding to the terminal domain of clathrin, Pitstop 2 disrupts the formation of clathrin-coated pits, thus interfering with epsin2's ability to promote endocytosis. Similarly, Chlorpromazine has been shown to disrupt clathrin-mediated endocytosis by preventing the assembly of clathrin at the plasma membrane, which would likely inhibit epsin2 function as it is involved in cargo selection during the formation of clathrin-coated vesicles. Tyrphostin A23 also targets this pathway by inhibiting the assembly of clathrin-coated pits, thereby reducing the functionality of epsin2 in vesicle formation and trafficking.
In addition to compounds that target clathrin directly, several inhibitors affect dynamin, a GTPase essential for the scission of clathrin-coated vesicles from the plasma membrane. Dynasore, Dyngo-4a, and MiTMAB are inhibitors that prevent dynamin from executing the GTP hydrolysis required for vesicle scission, which is a critical step in which epsin2 is involved. These compounds, therefore, indirectly inhibit epsin2 by blocking the final stage of clathrin-mediated endocytosis where epsin2 is active. Ocaperidone, while not a classical endocytosis inhibitor, interacts with components of the clathrin pathway, suggesting a potential to inhibit epsin2's role in this process. Ciliobrevin D, by inhibiting dynein, indirectly affects epsin2 as it may impede the transport of vesicles within the cell, thus altering the intracellular trafficking that epsin2 might regulate. EGA and Endosidin2 disrupt endosomal trafficking, which can limit epsin2's ability to sort endosomal cargo, thereby indirectly inhibiting its function. Lastly, Genistein's inhibition of tyrosine kinases can lead to a decrease in epsin2's role in receptor-mediated endocytosis, since phosphorylation events are often critical for the internalization of cargo molecules.
関連項目
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
Pitstop 2 | 1419093-54-1 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2は末端ドメインに結合することでクラスリンを阻害し、ε2が介在するエンドサイトーシスを減少させる可能性がある。 | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
ダイナソアはダイナミンGTPase活性を阻害するが、ダイナミンは小胞の分裂に必要であり、ε2がこの過程を促進する。 | ||||||
Hydroxy-Dynasore | 1256493-34-1 | sc-364678 | 10 mg | $250.00 | ||
ヒドロキシダイナソアはダイナミンを阻害し、ε2がエンドサイトーシスのプロセスを仲介するのを妨げることができる。 | ||||||
Dynamin Inhibitor II | 1119-97-7 | sc-203931 sc-203931A sc-203931B sc-203931C | 5 g 250 g 500 g 1 kg | $46.00 $82.00 $122.00 $194.00 | ||
ダイナミン阻害剤IIは小胞の分裂を阻害し、エンドサイトーシスにおけるε2の役割を阻害する可能性がある。 | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
クロルプロマジンはクラスリンを介するエンドサイトーシスを阻害し、ε2を機能的に阻害する可能性がある。 | ||||||
Ciliobrevin D | 1370554-01-0 | sc-507482 | 10 mg | $413.00 | ||
シリオブレビンDはダイニンを阻害し、細胞内小胞輸送を阻害することによって間接的にε2を阻害することができる。 | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
ゲニステインはチロシンキナーゼを阻害し、受容体を介するエンドサイトーシスにおけるε2の役割を減少させる可能性がある。 | ||||||
Tyrphostin A23 | 118409-57-7 | sc-3554 | 10 mg | $110.00 | 13 | |
チルホスチンA23はクラスリン依存性エンドサイトーシスを阻害し、ε2のエンドサイトーシス機能を低下させる可能性がある。 | ||||||